Search clinical trials for: Anti COVID 19 Antibodies

Total 170267 results

University of Arizona

Not yet recruiting

Biomarker Study: Heart Failure Patients at Risk

Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IV

United States
ProgenaBiome

Recruiting

A Study to Explore the Role of Gut Flora in COVID-19 Infection

Coronaviridae Infections | COVID-19 | COVID 19 | COVID | Corona Virus Infection | Coronavirus | Gastrointestinal Microbiome | Gut Microbiome | Coronavirus-19 | Coronavirus 19

United States
UCB Pharma SA

Completed

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis (C-early)

Rheumatoid Arthritis

Germany, United States, Argentina, Australia, Austria, Belgium, Canada, Colombia, Czechia, France, Hungary, Ireland, Italy, Mexico, Monaco, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, United Kingdom
UCB Pharma SA

Completed

Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures

Epilepsy | Partial Seizures

China
UCB Pharma GmbH

Completed

Observation of Treatment With Certolizumab Pegol in Daily Practice (FasT)

Rheumatoid Arthritis

Germany
Korea UCB Co., Ltd.

Completed

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy (OPTIMAL)

Epilepsy

Korea, Republic of
UCB Pharma

Completed

Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study (CERTAIN 2)

Rheumatoid Arthritis

Poland, Germany, Austria, France, Italy
InDex Pharmaceuticals

Completed

The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis (CONDUCT)

Ulcerative Colitis

Hungary, Czechia, France, Germany, Poland, Russian Federation, Serbia, Spain, Sweden, Ukraine
UCB Biopharma S.P.R.L.
Parexel

Completed

A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life (CIMAX)

Axial Spondyloarthritis

Belgium, Germany, Greece, Italy, Spain, United Kingdom
UCB Japan Co. Ltd.

Completed

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Epilepsy | Generalized Tonic-Clonic Seizures

China, Japan
UCB Pharma

Completed

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis (C-early)

Rheumatoid Arthritis

Germany, United States, Argentina, Australia, Austria, Belgium, Canada, Colombia, Czechia, France, Hungary, Ireland, Italy, Mexico, Monaco, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, United Kingdom
UCB Korea Co., Ltd.

Completed

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Epilepsy

Korea, Republic of
UCB Japan Co. Ltd.

Completed

An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy

Epilepsy | Partial Onset Seizures

Japan
UCB Pharma SA

Completed

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Epilepsy

Belgium, Finland, France, Germany, Hungary, India, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
UCB Pharma SA
Parexel

Completed

Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate

Rheumatoid Arthritis

Romania, United States, Australia, Austria, Bulgaria, Canada, Czechia, France, Germany, Greece, Hungary, Ireland, Italy, Mexico, Monaco, Poland, Portugal, Spain, Switzerland, United Kingdom
UCB BIOSCIENCES, Inc.

Completed

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures (ALEX-MT)

Epilepsy

Austria, United States, Australia, Canada, Denmark, France, Germany, Ireland, Italy, Poland, Puerto Rico, Spain, United Kingdom
UCB Pharma GmbH

Completed

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy (VICTOS)

Focal Epilepsy With and Without Secondary Generalization

Germany, Austria
UCB Pharma

Completed

Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) Patients (RA-PROACTIVE)

Arthritis,Rheumatoid

Ireland, United Kingdom
UCB Pharma

Terminated

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)

Rheumatoid Arthritis | Crohn's Disease

Russian Federation
UCB Japan Co. Ltd.

Completed

An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures

Epilepsy | Partial Seizures

Japan
UCB Korea Co., Ltd.

Completed

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Idiopathic Parkinson's Disease

Korea, Republic of
Brigham and Women's Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Physicians' Health Study

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease
Pierre Fabre Pharma GmbH
Pierre Fabre Pharma Austria; Pierre Fabre Pharma AG

Recruiting

Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment (BERING)

Melanoma Stage IV | Melanoma Stage III

Austria, Germany, Switzerland
Pierre Fabre Pharma AG

Completed

Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE). (Real-CHOICE)

Iron-Deficiency Anemia | Iron-Deficiency

Switzerland
Gaziler Physical Medicine and Rehabilitation Education...

Recruiting

Intermedius Genicular Nerve in the Treatment of Patients With Chondromalacia Patella

Chondromalacia Patellae

Turkey
UCB Pharma

Completed

Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation (AURORA)

Restless Legs Syndrome

Germany
UCB Pharma

Completed

Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription

Narcolepsy

Austria, Belgium, Czech Republic, Germany, Ireland, Italy, Spain, Switzerland, United Kingdom
UCB Pharma
Pivotal S.L.

Completed

Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine (RETO-PD)

Parkinson's Disease

Spain
Ghurki Trust and Teaching Hospital

Completed

Impact of Metal Density on Deformity Correction for Adolescent Idiopathic Scoliosis

Adolescent Idiopathic Scoliosis
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Drug-coated Balloon Therapy for In-stent Restenosis and de Novo Coronary Lesions

Coronary Heart Disease

China
Alessandra Mangia

Completed

Puglia HCV Micro-elimination Program (PHCVM)

Hepatitis C

Italy
Kahramanmaras Sutcu Imam University

Completed

Immature Granulocyte Count and Delta Neutrophil Index Factors for Axillary Metastasis of Breast Cancer

Breast Cancer | Breast Cancer Invasive
Gaziosmanpasa Research and Education Hospital

Completed

ATFL Evaluation With Ultrasound in Stroke Patients (ATFL)

Stroke Sequelae

Turkey
Meshalkin Research Institute of Pathology of Circulation

Withdrawn

Individualized Blood Pressure Management in Patients Undergoing Cardiac Surgery (PRECISE)

Cardiac Surgery

Russian Federation
Cairo University

Unknown

Combined 3D Power Doppler Placental Volume and Vascular Flow Indices In the First Trimester of Pregnancy as Predictors Of Preeclampsia?.

Preeclampsia

Egypt
COVID-19 Prevention Network

Completed

SARS-CoV-2/COVID-19 Prevalence Study

COVID-19

United States, Puerto Rico
Brigham and Women's Hospital
Centers for Disease Control and Prevention; Ministry of Health, Honduras

Recruiting

Home-based Care and Hand Hygiene Interventions in Honduras

Covid19

Honduras
Thiogenesis Therapeutics, Inc.

Not yet recruiting

Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19

COVID-19 | COVID-19 Acute Respiratory Distress Syndrome
Ottawa Hospital Research Institute
ISBRG Corp

Recruiting

SpotLight-19 Research & Development Study

Screening

Canada
Makerere University

Active, not recruiting

Hydroxychloroquine for Treatment of Non-Severe COVID-19 (HONEST)

Covid19

Uganda
Emory University

Withdrawn

Cetirizine and Famotidine for COVID-19

Covid19

United States
Medical College of Wisconsin
Children's Hospital and Health System Foundation, Wisconsin

Completed

Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell

Lymphoma, B-Cell | Lymphoma, Non-Hodgkin | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Sona Nanotech Inc
Nova Scotia Health Authority

Completed

Clinical Evaluation of the SONA Saliva C-19 Rapid Self-Test for the Detection of COVID-19

Sars-CoV-2 Infection

Canada
Perseverance Research Center, LLC
Athena Medical Group

Unknown

Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 (COVID-19)

COVID-19

United States
PATH

Completed

Feasibility and Usability of COVID-19 Antigen RDTs in Uganda

COVID-19 Pandemic

Uganda
US Oncology Research
Genentech, Inc.

Terminated

Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer

Breast Neoplasms | Malignant Tumor of the Breast

United States
Unidad Temporal COVID-19 en Centro Citibanamex
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Instituto...

Completed

Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19 (ANTIOX-COVID)

Pneumonia, Viral | Covid19 | Oxidative Stress | ARDS

Mexico
Bukwang Pharmaceutical

Completed

The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19

COVID-19

Korea, Republic of
Hasanuddin University
Chulalongkorn University

Completed

Post Coronavirus Disease (COVID-19) Syndrome Indonesian Population

Covid19

Indonesia
Raphael Serreau
Assistance Publique - Hôpitaux de Paris; University Hospital, Paris; François...

Completed

Epidemiological Study of the Covid-19 Presto Test - The "COVIDOR" Study (COVIDOR)

Coronavirus Infection

France

Search clinical trials for: Anti COVID 19 Antibodies

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations